MAA
ANGO icon

Managed Account Advisors’s AngioDynamics ANGO Stock Holding History

Managed Account Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$271K Sell
16,506
-268
-2% -$4.45K ﹤0.01% 2418
2015
Q1 		$299K Buy
+16,774
New +$312K ﹤0.01% 2349

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FMA
Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Managed Account Advisors's ANGO Position: Q2 2015 in Review

Managed Account Advisors reduced its AngioDynamics (ANGO) stake by 1.6% in Q2 2015, selling an estimated $4.45K and leaving 16,506 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #2418.

Managed Account Advisors first reported a position in ANGO in Q1 2015 and has held it in 2 quarters since. The position peaked at $299K in Q1 2015. 116 funds tracked by Wall St. Rank hold ANGO as of Q2 2015.

  • Managed Account Advisors held 16,506 shares of AngioDynamics worth $271K as of Q2 2015.
  • Managed Account Advisors sold 268 AngioDynamics shares in Q2 2015, an estimated $4.45K.
  • AngioDynamics made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2418 holding.
  • Managed Account Advisors first reported a position in AngioDynamics in Q1 2015 and has held it in 2 quarters since.
  • Managed Account Advisors's AngioDynamics position peaked at $299K in Q1 2015.
  • 116 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.